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ABSTRACT 
Objective:   Gastric acid secretory capacity in different anatomical regions, including the 
postprandial acid pocket, was assessed in H. pylori positive and negative volunteers in a 
Western population.  
 
Design:   We studied 31 H.pylori positive and 28 H.pylori negative volunteers, matched for 
age, gender and BMI.  Jumbo biopsies were taken at 11 pre-determined locations from the 
gastroesophageal junction and stomach.  Combined high resolution pHmetry (12 sensors) 
and manometry (36 sensors) was performed for 20 minutes fasted and 90 minutes 
postprandially. The squamocolumnar junction was marked with radio-opaque clips, and 
visualised radiologically.   Biopsies were scored for inflammation and density of parietal, 
chief and G cells immunohistochemically.  
 
Results:  Under fasting conditions, the H.pylori positives had less intragastric acidity 
compared to negatives at all sensors >1.1cm distal to the peak lower oesophageal sphincter 
(LES) pressure (p<0.01).  Postprandially, intragastric acidity was less in H.pylori positives at 
sensors 2.2, 3.3 and 4.4cm distal to the peak LES pressure (p<0.05), but there was no 
significant differences in more distal sensors. The postprandial acid pocket was thus 
attenuated in H.pylori positives.   
The H.pylori positives had a lower density of parietal and chief cells compared to H.pylori 
negatives in 10 of the 11 gastric locations (p<0.05).  17/31 of the H.pylori positives were 
CagA seropositive and showed a more marked reduction in intragastric acidity and 
increased mucosal inflammation.  
 
Conclusion: In population volunteers, H.pylori positives have reduced intragastric acidity 
which most markedly affects the postprandial acid pocket.    
  
Page 2 of 63
https://mc.manuscriptcentral.com/gut
Gut
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
3 
 
SUMMARY BOX 
 
WHAT IS ALREADY KNOWN? 
 
1. There is a negative association between H. pylori infection and both 
gastroesophageal reflux disease and oesophageal adenocarcinoma.   
2. The mechanism of this negative association is unclear but might be related to H. 
pylori reducing gastric acidity.  
3. The gastric acid which refluxes into the oesophagus originates from  the proximal 
gastric acid pocket.  
 
NOVEL FINDINGS: 
1. In population volunteers, intragastric acidity was less in those with H. pylori infection 
and this was most marked in the proximal stomach close to the gastroesophageal 
junction.   
2. The density of parietal cells and chief cells was reduced in H. pylori positives 
compared to negatives.   
3. The reduction in intragastric acidity and severity of inflammation were more marked 
in CagA positive versus CagA negative H. pylori infected subjects. 
 
CLINICAL IMPLICATIONS: 
 The reduced intragastric acidity close to the gastroesophageal junction in the H. 
pylori infected subjects provides a mechanism for the negative association between the 
infection and reflux disease and its complications.   
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INTRODUCTION 
   Helicobacter pylori (H.pylori) is a common bacterial infection of the stomach present in the 
majority of the world’s human population and resulting in varying degrees of inflammation of 
the underlying gastric mucosa.  The infection is acquired in early childhood and usually 
persists indefinitely unless specifically eradicated. [1] 
   One of the major medical advances of the past  25 years has been the discovery that this 
common infection plays an important role in the aetiology of duodenal and gastric ulcers and 
also of gastric cancer.[2]   Eradicating the infection produces a long-term cure for the majority 
of patients with peptic ulcers unrelated to NSAID therapy. There is also increasing evidence 
that eradication of the infection reduces the risk of gastric cancer.[3]  
   An unexplained observation regarding the infection is its negative association with 
gastroesophageal reflux disease (GERD) and its complications of Barrett’s oesophagus and 
oesophageal adenocarcinoma, with these disorders being less than half as common in 
infected subjects. [4, 5]   It has been postulated that this negative association may represent 
the gastric infection protecting against these oesophageal disorders.  If so, the falling 
incidence of the infection in the general population might explain the rising incidence of 
these oesophageal diseases.  
   One mechanism by which the infection might protect against oesophageal disease is by 
reducing the ability of the gastric mucosa to secrete acid and pepsin which are the 
constituents of gastric juice which can induce oesophageal damage.  The infection is known 
to exert varying effects on gastric secretory function.  In subjects with duodenal ulcers, the 
infection  produces a non-atrophic gastritis with well-maintained gastric secretory cell mass 
which secretes increased amounts of acid due to the infection inhibiting the gastrin-mediated 
negative feedback control of acid secretion.[6]  In patients who develop gastric cancer, the 
infection induces an atrophic gastritis with loss of gastric secretory cells and thus reduced 
acid secretion.  Only approximately 1 in 10 H.pylori infected subjects develop complicating 
ulcer disease or gastric cancer and relatively little is known about the effects of the chronic 
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infection on gastric secretory function in the 90% of infected subjects without these 
complications.[7]   If the degree of reduction in oesophageal disease in the H.pylori infected 
population is due to the infection reducing gastric acid secretion, then this suppression of 
acid secretion would need to be apparent in the majority of infected subjects. 
   Recent evidence indicates that it is the acidity of the gastric contents close to the 
gastroesophageal junction (GEJ), referred to as the acid pocket, which refluxes and causes 
oesophageal damage.[8]  It is also known that loss of gastric secretory cells due to H.pylori-
induced atrophic gastritis does not occur uniformly throughout the stomach but may be more 
marked at the periphery of the acid secreting mucosa.[9]   In assessing any potential 
protective effect of the infection against oesophageal damage, it is important to examine the 
structure and secretory function of different anatomical regions of the stomach as well as its 
overall secretory capacity. 
   The aim of our study was to assess gastric secretory status in different anatomical regions 
of the stomach and in subjects representative of the majority of the H.pylori infected 
population. 
   
METHODS & MATERIALS 
Subjects 
     Study participants were volunteers from the general population of the West of Scotland.   
Subjects who were currently taking, or had recently taken, proton pump inhibitors,  were 
currently using H2 receptor antagonists or had ever received H.pylori eradication therapy 
were excluded.  Recruitment was by general advertisement and from the NHS Scotland 
SHARE database.    
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Study design 
Study Day 1: Clinical measurements and Urea breath test 
     The presence and severity of any gastrointestinal symptoms was assessed  using the 
Short-Form Leeds Dyspepsia Questionnaire [10] and a medication history was recorded.  
Measurements of height, weight, waist and hip circumference were taken.  Volunteers were 
tested for H.pylori infection by C14 urea breath test.  Fasting serum and plasma samples 
were stored at -20˚C and later tested for H.pylori CagA IgG using ELISA (Genesis 
Diagnostics Ltd, Littleport, UK).  
 
Study day 2: Upper gastrointestinal endoscopy 
     Volunteers attended after an overnight fast for upper gastrointestinal endoscopy.   They 
were offered topical lidocaine throat spray or conscious sedation with midazolam 1-3mg.  
Biopsies were taken using large capacity biopsy forceps (Radial Jaw™ 4; Boston Scientific, 
Hemel Hempstead, UK) with a jaw span of 8mm.  Two junctional biopsies were taken 
perpendicular to the squamocolumnar junction (SCJ), one from lesser and one from greater 
curve,  and targeted to include squamous mucosa at the proximal end.  Three further 
junctional biopsies were taken longitudinally below the SCJ, aiming for end-to-end biopsies 
starting at 6, 12 and 18mm distal to the SCJ down the lesser curve.  In addition, six further 
gastric biopsies were taken from gastric fundus, mid-body on greater curve, mid-body on 
lesser curve, distal body on greater curve, incisura angularis and antrum.  Finally, two small 
metal radio-opaque clips were attached to the SCJ using a single use rotatable clip fixing 
device (QuickClip 2™; Olympus, Southend-on-Sea, UK). 
 
Biopsy specimen processing 
     Biopsies were immediately placed onto non-adherent dental wax and oriented flat.  More 
detailed information concerning the two-stage orientation method has been described 
elsewhere.[11]   The specimens were later embedded in agar on the filter paper without 
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further manipulation.  Staining was performed with conventional H&E, as well as monoclonal 
antibodies to H+/K+ATPase, pepsinogen I and gastrin. 
 
Study Day 3: Combined manometry and pH study 
     The volunteers attended after an overnight fast for combined high resolution manometry 
and pH studies.  The combined probe was  passed pernasally and positioned so that the 
most proximal pH sensor was 5cm above the lower oesophageal sphincter (LES), with the 
remaining eleven sensors lying across the sphincter and within the proximal stomach.  The 
relative positions of the 12 sensor pH catheter, 36 sensor manometer and SCJ is shown in 
Fig 1.  Manometry and pH data were recorded concurrently for a 20 minute fasting period.  
Subjects then consumed a standardised meal over ten minutes [400g Waitrose spaghetti 
bolognese ready meal and 100ml water (500kcal; 55.2g carbohydrate, 27.8g protein, 17.6g 
fat)].  Following this, manometry and pH recordings were continued for a further 90 minutes.  
An X-ray was taken before and after the meal to visualise the metal clips at the SCJ. 
 
Equipment 
High-resolution pHmetry    
     pH recordings were taken using a high resolution pH catheter (Synectics Medical Ltd, 
Enfield, UK).  This was a custom-made pH probe composed of 12 antimony pH electrodes 
with the most distal electrode situated 5mm from the tip of the catheter, with the other eleven 
electrodes 35, 46, 57, 68, 79, 90, 101, 112, 123, 134 and 169mm proximal to the tip.  The 
probe was calibrated prior to each study using pH buffer solution (Synmed Ltd, Enfield, UK) 
at pH 7.01 and pH 1.07.  Recordings were captured using Polygram Net software (Synectics 
Medical Ltd, Enfield, UK). 
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High-resolution manometry  
     Manometry was performed using a high resolution solid-state catheter with 7.5mm 
spacing between 36 circumferential sensors (Given Imaging, Hamburg, Germany).   
Calibration was performed prior to each study and In vivo calibration was carried out on a 
weekly basis and applied to each study to compensate for thermal drift.  Recordings were 
captured with ManoScan 360 high-resolution Manometry System and analysed with 
ManoView ESO v3.0.1 software (Given Imaging, Hamburg, Germany).   
 
Combined probe  
    The manometry and pH catheters were combined using two thin strips of Leukoplast 
Sleek waterproof tape (BSN Medical, Pinetown, SA) such that manometry sensor 25 was 
immediately adjacent to pH sensor 3.   
 
Data analysis 
Intragastric acid 
     The 90 minute postprandial period was split into three 30 minute periods for analysis.  
The median pH for each of the 12 pH sensors was calculated for the twenty minute fasting 
period and the three 30 minute postprandial periods.  Acid exposure at the GEJ was also 
examined by calculating the % of time pH <4.    
 
Manometry  
     Manometric characteristics were analysed in detail during fasting and the same three 
postprandial periods.  For each two minute period, one inspiratory point and one expiratory 
point was chosen from the longest period without interference from swallowing, coughing or 
transient lower oesophageal sphincter relaxations (TLESRs).  The mean pressure in 
inspiration and expiration was calculated for each of the 36 sensors over the twenty minute 
fasting period and thirty minute postprandial periods.  The peak LES pressure was taken as 
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the sensor showing the highest mean pressure.  The position of the SCJ was derived from 
the position of the metal clips relative to the combined manometry and pH sensors seen on 
X-ray. 
 
Histopathological Assessment 
A.   Studies using Conventional H&E: 
Glandular height:  The vertical height of epithelium starting from lamina propria to tip of 
gland were measured in 3 well-oriented and representative fields and expressed as “Total 
Thickness of Epithelium”.  To measure the “Glandular Height”, the same method was limited 
to areas of gland containing secretory cells, but not superficial foveolar epithelial cells.  All 
results were expressed as median (IQR) in mm. 
Inflammatory scoring:  The intensity of inflammatory infiltrate by polymorphonuclear (PMN) 
and mononuclear (MN) cells was scored semi-quantitively (0=none; 1=mild; 2=moderate; 
3=severe) as recommended in the Updated Sydney Classification of Gastritis [12].    A 
combined inflammatory score was calculated as the sum of these two scores.   Intestinal 
metaplasia (IM) was scored by estimating the proportion of epithelial surface covered by 
goblet cells. 
 
B.   Immunohistochemistry   
     The oriented biopsies, double embedded in agar and paraffin, were cut in standard 4-
micron thickness and immunostained individually for parietal cell, chief cell and G cells.  For 
parietal cells, we used a commercial mouse monoclonal anti-H+/K+ ATPase (Ab 2866, 
Abcam, Cambridge, UK) diluted at 1:20,000.  For Chief cells, a mouse monoclonal anti-
pepsinogen 1 antibody (Ab 50123, Abcam, Cambridge, UK) was used at dilution of 1:4000.  
The G cells were stained with anti-gastrin (Ab-16035, Abcam, Cambridge, UK) diluted at 
1:200.  A Thermo Quanto Detection Kit (TL-125-OHD, Thermo Fisher, UK) was used as 
secondary antibody. 
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Quantification of Secretory Cells: 
     To calculate the density of parietal cells, chief cells and G cells, absolute number of 
stained cells were counted at a magnification of 125X in 3 well-oriented and representative 
fields (1 mm2 each) and expressed as mean cell number per 1 mm2 area in each patient.  All 
selected areas must have had complete glands located in sagittal plane, in which the lamina 
propria was in bottom and luminal side of epithelium was in top. 
 
Statistical analysis 
     All continuous data are expressed as medians and interquartile ranges unless otherwise 
stated.  Comparison of variables between groups was made using the Mann-Whitney U test.  
Biopsy inflammatory scores are presented as crosstabulations and compared using Fisher’s 
exact test.  Significance for all statistical tests was set as p value <0.05. 
 
Ethics 
     The study protocol was approved by the West of Scotland Ethics Committee and all 
volunteers provided informed written consent. 
 
RESULTS 
     Of the 137 subjects assessed for eligibility for the study, 49 were excluded due to current 
or recent use of proton pump inhibitor (PPI) therapy (n=9) or history of previous H.pylori 
eradication therapy (n=8) or declining to participate following full explanation of the study 
protocol (n=32).  88 subjects proceeded to the urea breath test of which 31 were H.pylori 
positive and all of these went on to complete the full study protocol.  Of the 57 testing 
H.pylori negative, 28 went on to complete the study due to 1 withdrawing consent after the 
endoscopy and 28 not being selected to proceed in order to maintain matching of the 
positive and negative groups with respect to age, gender and body mass index (BMI) (Fig. 
S1).   
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     The 31 H.pylori positive and 28 H.pylori negative subjects who completed the study were 
well matched with respect to age (55 vs 56 years; p=0.95), gender (18/31 vs 18/28 males; 
p=0.84) and BMI (26.3 vs 26.8 kg/m2; p=0.72). There were 7 current smokers in the H.pylori 
positive group compared to 1 current smoker in the H.pylori negative group (p=0.035). 
     The median dyspepsia score for H.pylori positives was 2.0 (range 0-9) compared to 0 
(range 0-3) for the H.pylori negative subjects (p=0.002).  17/31 (54.8%) of the H.pylori 
positives were taking no medication compared to 10/29 (35.7%) of the H.pylori negative 
subjects.  The most frequent medications were antihypertensives, statins, antidepressants 
and inhalers for asthma.  No subject was taking medications known to affect gastric 
secretion.  
     At endoscopy, 4 H.pylori positive subjects had a hiatus hernia (2-4cm in length), 1 subject 
had LA Grade A reflux esophagitis, and one subject had 3cm of Barrett’s mucosa.  None of 
the H.pylori negatives had a hiatus hernia, although two subjects had reflux esophagitis (LA 
grade A and B).  
 
Gastroesophageal Acidity 
     Under fasting conditions, the H.pylori positive subjects had less intragastric acidity 
compared to the H.pylori negatives at all sensors more than 1.1cm distal to the peak LES 
pressure (Table 1).  The fall from neutral oesophageal pH to highly acidic intragastric pH 
also occurred more abruptly in the H.pylori negatives.  At the sensor 3.3cm distal to the peak 
LES pressure, the median pH in the H.pylori negatives had fallen to 2.27 compared to 6.13 
in the positives (p<0.001).  The radio-opaque clips indicated that this pH sensor was 1.8cm 
distal to the SCJ.  
     Throughout the three postprandial periods, intragastric acidity was significantly less in the 
H.pylori positives at the pH sensors placed 2.2, 3.3 and 4.4cm distal to the peak pressure of 
the LES but no significant difference was detected by the more distal sensors placed at 5.5 
and 6.6cm distal to this reference point (Table 1).  These three sensors detecting a 
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significant difference in gastric acidity between the two groups were those closest to the GEJ 
with the most proximal of them being only 0.6cm distal to the SCJ (Fig. 2).   
     The % of time pH<4 for each of the three postprandial periods was significantly greater in 
the H.pylori negatives versus positive subjects for the electrodes extending 3cm distal to the 
peak LES pressure, at the peak LES pressure and also extending 1.1cm above the peak 
LES pressure (Table 2). 
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Table 1. Median (IQR) pH values at sensors relative to peak LES pressure comparing H.pylori negative (n=28) and positive (n=31) groups 
during 20 minute fasting period and three 30 minute postprandial periods.. 
 
 Fasting  0-30 minutes  30-60 minutes  60-90 minutes 
Sensor location HP- HP+ p value  HP- HP+ p value  HP- HP+ p value  HP- HP+ p value 
5cm proximal 
7.20 
(0.70) 
7.19 
(0.74) 
0.933  
7.28 
(0.79) 
7.03 
(0.72) 
0.274  
7.18 
(0.81) 
6.98 
(0.77) 
0.499  
7.13 
(0.85) 
7.04 
(0.67) 
0.861 
1.1cm proximal 
7.33 
(0.78) 
7.37 
(0.62) 
0.525  
7.20 
(0.96) 
7.29 
(0.68) 
0.443  
7.06 
(1.42) 
7.00 
(0.75) 
0.705  
7.13 
(1.77) 
6.96 
(1.27) 
0.786 
Peak LES pressure 
7.34 
(0.79) 
7.28 
(0.51) 
0.499  
6.83 
(0.62) 
6.94 
(0.66) 
0.339  
6.76 
(1.02) 
6.88 
(0.48) 
0.391  
6.56 
(1.27) 
6.77 
(0.58) 
0.245 
1.1cm distal 
7.06 
(1.63) 
7.13 
(0.51) 
0.213  
5.90 
(1.88) 
6.74 
(1.18) 
0.063  
5.25 
(4.19) 
6.40 
(1.72) 
0.053  
6.43 
(4.80) 
6.38 
(2.21) 
0.306 
2.2cm distal 
5.79 
(4.26) 
6.94 
(1.38) 
0.004  
3.17 
(3.07) 
5.55 
(2.84) 
0.005  
1.95 
(1.00) 
3.21 
(4.46) 
0.005  
2.20 
(2.82) 
3.82 
(4.40) 
0.024 
3.3cm distal 
2.27 
(2.58) 
6.13 
(5.06) 
<0.001  
2.46 
(2.75) 
4.26 
(2.84) 
0.006  
1.59 
(1.08) 
2.07 
(2.29) 
0.009  
1.61 
(0.82) 
2.30 
(3.08) 
0.010 
4.4cm distal 
1.70 
(1.16) 
4.11 
(4.95) 
<0.001  
4.09 
(3.17) 
4.87 
(1.60) 
0.025  
1.81 
(2.09) 
2.93 
(3.25) 
0.032  
1.67 
(0.94) 
2.01 
(2.10) 
0.031 
5.5cm distal 
1.68  
(0.66) 
2.88 
(3.66) 
<0.001  
4.62 
(1.21) 
4.79 
(1.36) 
0.309  
2.13 
(2.02) 
3.48 
(2.89) 
0.062  
1.74 
(1.45) 
2.36 
(2.74) 
0.078 
6.6cm distal 
1.62 
(3.66) 
2.39 
(3.06) 
0.003  
4.60 
(1.17) 
4.68 
(0.96) 
0.313  
3.39 
(2.19) 
4.10 
(2.23) 
0.158  
2.08 
(1.58) 
3.87 
(2.35) 
0.184 
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Table 2: Median (IQR) percentage time pH<4 at sensors relative to peak LES pressure comparing H.pylori negative (n=28) and positive 
(n=31) groups during 20 minute fasting period and three 30 minute postprandial periods. 
 
 Fasting  0-30 minutes  30-60 minutes  60-90 minutes 
Sensor location HP- HP+ p value  HP- HP+ p value  HP- HP+ p value  HP- HP+ p value 
5cm proximal 
0.0 
(0.0) 
0.0 
(0.0) 
0.271  
0.2 
(0.4) 
0.0 
(0.7) 
0.384  
0.0 
(0.7) 
0.0 
(0.5) 
0.354  
0.0 
(1.2) 
0.0 
(0.5) 
0.280 
1.1cm proximal 
1.1 
(2.8) 
0.0 
(0.1) 
0.004  
3.0 
(2.8) 
0.0 
(1.3) 
0.005  
2.1 
(14.3) 
0.3 
(2.8) 
0.046  
2.0 
(6.4) 
0.6 
(0.7) 
0.088 
Peak LES pressure 
1.7 
(4.9) 
0.0 
(1.0) 
0.001  
4.2 
(6.5) 
0.6 
(2.0) 
<0.001  
3.7 
(15.3) 
0.9 
(4.4) 
0.017  
2.7 
(8.7) 
1.2 
(7.4) 
0.162 
1.1cm distal 
6.6 
(30.6) 
1.0 
(7.3) 
0.008  
15.4 
(30.8) 
1.8 
(19.3) 
0.003  
33.9 
(67.0) 
5.2 
(33.0) 
0.021  
7.6 
(77.1) 
10.1 
(25.5) 
0.264 
2.2cm distal 
32.1 
(65.4) 
2.8 
(21.7) 
0.004  
62.9 
(49.7) 
22.6 
(51.8) 
0.001  
90.8 
(28.7) 
63.2 
(81.1) 
0.002  
81.1 
(51.7) 
55.1 
(84.7) 
0.026 
3.3cm distal 
75.6 
(48.2) 
13.5 
(75.6) 
0.003  
64.9 
(45.7) 
46.4 
(66.1) 
0.004  
99.7 
(9.3) 
91.5 
(49.0) 
0.017  
99.2 
(3.2) 
91.0 
(59.1) 
0.009 
4.4cm distal 
93.0 
(42.3) 
42.4 
(42.3) 
<0.001  
44.2 
(69.2) 
15.1 
(53.0) 
0.032  
99.0 
(18.7) 
88.9 
(77.9) 
0.111  
100.0 
(3.0) 
99.4 
(20.7) 
0.043 
5.5cm distal 
97.6 
(14.0) 
60.4 
(62.1) 
0.001  
24.3 
(47.4) 
12.9 
(48.5) 
0.375  
96.2 
(37.3) 
86.1 
(88.2) 
0.083  
100.0 
(1.2) 
99.8 
(80.1) 
0.105 
6.6cm distal 
99.5 
(4.8) 
84.8 
(61.6) 
0.011  
13.7 
(46.4) 
9.9 
(21.7) 
0.355  
82.8 
(72.6) 
38.5 
(99.3) 
0.104  
99.8 
(9.0) 
96.8 
(61.0) 
0.099 
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Gastric Histopathology 
A.   Conventional H&E Staining 
Inflammation 
     The H.pylori positives had a greater combined inflammatory cell infiltrate at each of the 
11 biopsy sites compared to the H.pylori negatives (Table 3).  The increased combined 
inflammatory cell infiltrate in the H.pylori positives consisted of a mixture of PMN cells and 
MN cells and tended to be more intense close to the SCJ, lesser curve, distal stomach, 
incisura and antrum compared to the gastric fundus and mid-body (p<0.05 for each).  The 
H.pylori negatives had a MN cell infiltrate limited to the SCJ and also to a lesser extent at the 
antrum and angularis incisura but its intensity was less than that of the H.pylori positives at 
these sites.  There was minimal evidence of PMN cell infiltrate at any location in the H.pylori 
negatives.  
 
Intestinal Metaplasia 
     Intestinal metaplasia was identified in 14 of the 31 H. pylori positive subjects.  In 7 of 
these it was limited to one or more of the biopsies from mid-body lesser curve, distal body 
greater curve, incisura angularis and antrum.  In 3 of the subjects it was present in at least 
one of the above sites and also in the biopsies close to the SCJ.  In a further 3 it was limited 
to the region close to the SCJ.  In 1 subjects it was present in each biopsy except for one of 
the biopsies from the SCJ.  
     Intestinal metaplasia was identified in only four of the 28 H.pylori negative subjects.  In 
three of these it was only seen in the biopsies across the SCJ and in the fourth subject it was 
only seen in the biopsy from the fundus. 
 
Gastric Gland Height 
     The height of the gastric secretory glands was significantly reduced in the H.pylori 
positive versus negative subjects throughout the gastric mucosa except for the biopsies 
taken across the SCJ (Table 4).  
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Table 3: Cross-tabulation table showing the number of subjects within the H.pylori negative (HP-) and positive (HP+) groups with each combined 
inflammatory score (0-6) at the 11 different gastric biopsy locations. 
 
Combined 
Inflammatory 
score 
Across SCJ 
(greater curve) 
 Across SCJ 
(lesser curve) 
  
6mm distal SCJ 
  
12mm distal SCJ 
  
18mm distal SCJ 
  
HP- HP+   HP-  HP+   HP- HP+   HP- HP+   HP-  HP+    
0 8 0  1 0  15 0  25 0  26 0    
1 10 0  16 0  8 1  2 1  1 4    
2 9 0  6 0  1 3  0 6  0 7    
3 1 7  0 7  0 10  0 8  1 9    
4 0 11  0 11  0 11  0 11  0 5    
5 0 11  0 9  0 5  0 4  0 4    
6 0 1  0 0  0 0  0 0  0 1    
Fisher’s Exact 
test 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001   
            
Combined 
Inflammatory 
score 
 
Fundus 
 Mid-body, 
 lesser curve 
 Mid-body, 
 greater curve 
 Distal body, 
greater curve 
  
Incisura angularis 
  
Antrum 
HP- HP+   HP- HP+   HP- HP+   HP- HP+   HP- HP+   HP- HP+  
0 25 0  25 0  27 0  24 0  17 0  14 0 
1 1 5  2 0  0 2  2 0  9 0  9 0 
2 0 6  0 6  0 8  0 7  1 0  0 0 
3 1 12  0 11  0 8  0 5  0 6  1 1 
4 0 5  0 6  1 5  1 7  0 3  0 6 
5 0 1  0 4  0 4  1 8  0 13  0 11 
6 0 2  0 4  0 4  0 4  0 9  0 8 
Fisher’s Exact 
test 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001 
 
  
Page 16 of 63
https://mc.manuscriptcentral.com/gut
Gut
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
17 
 
 
Table 4. Median (IQR) of glandular thickness and densities of parietal and chief cells at each biopsy location comparing H.pylori negatives (n=28) and 
positives (n=31). 
 
 Glandular Thickness (mm)  Parietal cell density (cells/mm
2
)  Chief cell density (cells/mm
2
) 
Biopsy location H.pylori - H.pylori + P value  H.pylori - H.pylori + P value  H.pylori - H.pylori + P value 
Across SCJ, Greater curve 
0.30 
(0.20–0.30) 
0.25 
(0.20–0.30) 
0.515  
67 
(0-162) 
17 
(10-39) 
0.185  
94 
(0-156) 
22 
(3-52) 
0.150 
Across SCJ, Lesser curve 
0.28 
(0.0–0.30) 
0.20 
(0.10–0.30) 
0.461  
50 
(14-127) 
9 
(0-51) 
0.012  
89 
(17-139) 
22 
(0-62) 
0.017 
6mm distal SCJ 
0.35 
(0.30–0.40) 
0.30 
(0.20–0.30) 
0.006  
231 
(175-286) 
144 
(59-190) 
<0.001  
245 
(203-272) 
129 
(52-190) 
<0.001 
12mm distal SCJ 
0.40 
(0.40–0.45) 
0.30 
(0.30–0.35) 
<0.001  
317 
(300-362) 
193 
(137-250) 
<0.001  
379 
(312-404) 
206 
(125-299) 
<0.001 
18mm distal SCJ 
0.45 
(0.40–0.50) 
0.35 
(0.30–0.40) 
<0.001  
357 
(334-383) 
241 
(201-283) 
<0.001  
404 
(374-421) 
273 
(194-353) 
<0.001 
Fundus 
0.43 
(0.40–0.45) 
0.40 
(0.35–0.40) 
0.008  
347 
(285-401) 
258 
(220-292) 
<0.001  
421 
(384-451) 
310 
(255-389) 
<0.001 
Mid-body, Lesser curve 
0.40 
(0.40–0.45) 
0.35 
(0.30–0.40) 
<0.001  
361 
(316-381) 
235 
(166-290) 
<0.001  
401 
(367-419) 
285 
(206-367) 
<0.001 
Mid-body, Greater curve 
0.45 
(0.40–0.45) 
0.35 
(0.30–0.40) 
<0.001  
356 
(318-398) 
250 
(201-297) 
<0.001  
420 
(372-441) 
305 
(243-354) 
<0.001 
Distal body, Greater curve 
0.40 
(0.35–0.49) 
0.30 
(0.25–0.35) 
<0.001  
322 
(293-349) 
107 
(25-263) 
<0.001  
365 
(296-398) 
136 
(17-292) 
<0.001 
Incisura Angularis 
0.33 
(0.30–0.40) 
0.25 
(0.20–0.30) 
<0.001  
203 
(124-250) 
12 
(0-87) 
<0.001  
215 
(98-296) 
7 
(0-99) 
<0.001 
Antrum 
0.20 
(0.13–0.30) 
0.20 
(0.0–0.20) 
0.041  
40 
(6-67) 
7 
(0-18) 
0.002  
22 
(1-85) 
0 
(0-5) 
<0.001 
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B.   Immunohistochemistry 
Parietal and Chief Cell Density: 
     The H.pylori positives had a significant reduction in density of both parietal and chief cells 
compared to H.pylori negatives, and this was seen at each of the 11 intragastric locations 
assessed except for the SCJ greater curve where the difference did not achieve statistical 
significance (Table 4).  The degree of reduction was similar for the two cell types.     
     The depletion of both cells in the H.pylori positives versus negatives was more marked in 
the biopsies taken from the distal gastric mucosa (i.e. antrum, incisura angularis, and distal 
body greater curve) being reduced by 67-100% compared to that observed in the more 
central region of the oxyntic mucosa (fundus and mid-body) at 26-35% (Fig. 3).   In addition, 
the length of mucosa extending distal to the SCJ which contained no detectable parietal cells 
was greater in the H.pylori positives versus negatives (1.5mm vs 1.0mm; p=0.013). 
However, the degree of reduction in specialised cell density in the biopsies taken 6mm and 
12mm distal to the SCJ (38-47%) was not dissimilar from that observed in the more central 
oxyntic mucosa (i.e. fundus and mid-body) (26-35%) (Fig. 3).   
 
G Cell Density 
     The density of G cells was reduced in the antrum of the H.pylori positive versus negative 
subjects [48 (IQR: 31-86) vs. 91 (64-129), p<0.001], but the converse was seen with respect 
to the biopsies taken from the distal body region [0 (IQR: 0-32) vs 0 (0-0), p=0.007]. 
 
Intragastric Acidity and Histology in CagA Positive H.pylori Subjects 
     Seventeen of the H.pylori positives were CagA seropositive and fourteen CagA 
seronegative.  The associations with reduced intragastric acidity in comparison with H.pylori 
negatives was more apparent for the CagA positives being significant for five of the six 
intragastric sites both fasting and after the meal in the CagA positives but in only two of the 
six intragastric sites for the CagA negatives and only under fasting conditions (Table 1 – 
supplement).  There was a statistically significant difference between the CagA negative and 
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CagA positives for only two of the six sites during fasting and one of the six sites after the 
meal.   
     The CagA positives had a significantly greater combined inflammatory cell infiltrate 
evident at three of the eleven biopsy locations (6mm and 18mm distal SCJ, and distal body 
greater curve), compared to the CagA negatives (Table 2 – supplement).  The reduction in 
parietal and chief cell density was significant at each intragastric location for both CagA 
positive and negative subjects with no apparent difference between these two groups.   
 
DISCUSSION 
     In our volunteers recruited from the general population of the West of Scotland, those 
with H.pylori infection had less intragastric acidity both under fasting conditions and following 
a meal compared to uninfected volunteers matched for age, gender and BMI.  In addition, 
those with the infection had a reduced density of both acid secreting parietal cells and 
pepsin producing chief cells compared to those uninfected.  These findings indicate that 
H.pylori infection within our Western population is associated with a less acidic and 
proteolytic intragastric environment. 
     The reduced intragastric acidity in the H.pylori positive subjects was apparent throughout 
the stomach under fasting conditions.  After the meal, however, the reduced acidity in the 
H.pylori positives was evident within the first few centimetres distal to the GEJ but no 
significant difference in acidity was apparent in the main body of the stomach.  There was 
also evidence of increased acidity after the meal in the H.pylori negatives right at the SCJ 
junction and extending 2cm above it indicating increased intrasphincteric acid reflux.  We 
and others have previously reported that the proximal region of the stomach close to the 
GEJ largely escapes the buffering effect of ingested food and may remain highly acidic after 
a meal.[13,14,15]  This phenomenon has been called the acid pocket and is thought to be 
important in GERD induced oesophageal damage after a meal when reflux is most common.  
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It is therefore interesting that it is at this region close to the GEJ where the reduced acidity 
was most apparent in the H.pylori infected subjects. 
     What is the reason for the reduced acidity in the H.pylori positives after a meal, being 
most marked close to the GEJ?  There was no evidence that the depletion in parietal cell 
density in the H.pylori positives was more pronounced over the few centimetres close to the 
GEJ compared to other regions in the stomach.  Inflammation may also inhibit gastric 
secretory function [16] and this was slightly increased close to the GEJ and also in the distal 
stomach compared to the mid-body gastric mucosa.   The elevation of intragastric pH 
following the meal in the H.pylori positives being most marked close to the GEJ may simply 
reflect the relative intragastric distribution of gastric juice and ingested food.  Following a 
meal, the food occupies the centre of the stomach and the secreted gastric juice,  the region 
close to the stomach wall which secretes it.  Impaired acid secretion will elevate the pH of 
the gastric juice and this will be most apparent close to the stomach wall.  In contrast, the 
central region of the stomach will reflect the pH of the food and thus will be relatively 
unaffected by changes in the acidity of secreted juice.  The effect of H.pylori on intragastric 
pH after the meal being most evident close to the GEJ may be due to this region being close 
to the wall of the stomach.  
     Whatever the explanation for the changes in acidity between H.pylori positives and 
negatives being most marked close to the GEJ, after the meal, the observation is likely to be 
important with respect to the propensity of gastroesophageal reflux producing oesophageal 
damage.  It is well recognised that gastric juice which refluxes into the oesophagus is that 
present close to the GEJ and also that reflux most commonly occurs during the postprandial 
period when TLESRs are most frequent. [17] 
     The reduction in parietal cell density observed in the H.pylori positive subjects was 
associated with a similar reduction in chief cell density.  This is consistent with the infection 
and inflammation causing a loss in gastric glands and also with the previous literature 
showing that the development of parietal and chief cells is intimately linked.[18]   We did not 
measure the secretion of pepsin and other digestive enzymes produced by the chief cells but 
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their reduced density is likely to be associated with reduced secretory capacity after the 
meal.  Reduction in gastric juice peptic activity has previously been reported in H.pylori 
infected subjects.[19]   The peptic activity of the gastric juice is as important, and arguably 
more important than its acidity, with respect to the ability to damage oesophageal mucosa 
and therefore the reduction in both specialised cells is likely to represent a substantial 
reduction in the damaging capacity of reflux gastric juice in H.pylori infected subjects. [20]  
     There was a reduction in the density of G cells in the antrum of the H.pylori positives 
indicating a depletion of antral as well as oxyntic glands.  In contrast, G cell density in the 
distal body mucosa of the H. pylori positives was higher than in the H. pylori negative 
subjects.  This can be explained by the distal acid secreting body mucosa, which does not 
have G cells, being replaced by an antral-like mucosa that contains G cells (a process that 
has been called “antralization”).  This process can be associated with the development of 
pseudo-pyloric metaplasia, also called spasmolytic polypeptide expressing metaplasia 
(SPEM). [21-24]  This is consistent with our observation that the reduction in parietal and 
chief cell densities in H. pylori positives was most pronounced in the distal body mucosa.  
Together these findings are likely to represent the previously reported proximal progression 
of the junction between the antrum and body type mucosa leading to shrinkage in the 
surface area of the stomach covered by oxyntic mucosa in H. pylori atrophic gastritis.  [25]     
     There are few previous studies assessing gastric secretory function in H.pylori infected 
healthy volunteers in the Western world.  In a retrospective analysis of 95 healthy, young 
male volunteers (age 19-26 years) Smith et al reported that the 8 seropositive for H.pylori 
had similar intragastric acidity to the other 87. [26]   In a retrospective analysis of 136 healthy 
volunteers, Peterson et al reported reduced basal acid output but no significant difference in 
gastrin stimulated peak acid output or meal stimulated acid output assessed by intragastric 
titration in H.pylori seropositives.[27]  In a prospective study of 206 healthy volunteers, 
Feldman et al. in 1996 reported reduced gastrin stimulated peak acid output and reduced 
basal pepsin output in those with H.pylori detected histologically in gastric biopsies.[28]   In 
1998, our own group reported a reduced acid secretory response to gastrin stimulation in 20 
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H.pylori positive versus 24 H.pylori negative healthy volunteers.[29]   Several studies in the 
Japanese population have reported reduced gastric secretory function in H.pylori positive 
healthy volunteers.[30,31]  
     Our current study differs from previously published studies in a number of important 
respects.  Firstly, we aimed to study subjects representative of the general population 
infected with H.pylori  rather than asymptomatic healthy volunteers.  Secondly, by using  
intragastric pH sensors, we avoided the use of non-physiological gastric stimuli, gastric 
aspiration or intragastric titration which may not be representative of the subjects usual 
gastric functioning.   Thirdly, we focused on the middle-aged population rather than young 
students as the former is the population in whom reflux disease manifests itself.  Finally, and 
probably most critically, we employed a technique which allowed us to assess the acidity in 
different regions of the stomach and in particular close to the GEJ.  
     Our observation that gastric acidity was reduced most markedly close to the GEJ is 
interesting in the light of the previously reported but unexplained observations by Feldman et 
al in 1999.  They observed that in healthy volunteers, eradication of H.pylori did not alter 
basal or meal-stimulated gastric acid secretion assessed by intragastric titration but did 
result in a 2-3 fold increase in gastroesophageal acid reflux.[32]   In the light of our current 
study, the observed increase in gastroesophageal acid reflux may have been explained by 
the H.pylori infection reducing intragastric acidity close to the GEJ.  
     Is our finding of reduced gastric secretory function in the H.pylori infected population a 
peculiar feature of our West of Scotland population or relevant to the wider Western 
community?  H.pylori induced atrophic gastritis and reduced acid secretory function is 
associated with gastric cancer and the prevalence of the two correlates at a population 
level.[33]  The incidence of gastric cancer in Scotland is 9.7 /100,00py and similar to that of 
Western European and North American countries and substantially lower than that of 
Eastern European and Far Eastern countries.[34]  This would suggest that our findings of 
reduced acid secretory function is representative of what is happening in Western countries.   
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     Though our study demonstrates that the H.pylori infected general adult population has 
less intragastric acidity than the uninfected population, this association does not necessarily 
indicate that the reduced intragastric acidity is caused by the infection.  However, causal 
association seems highly likely as H.pylori gastritis is recognised to cause loss of gastric 
glands and impaired secretory function.  In addition, the more marked changes in gastric 
secretory function in those with the more virulent CagA strain supports it being caused by 
the infection.  Confirming causality by an intervention study has potential problems as 
H.pylori-induced loss of gastric glands is generally regarded as being irreversible. 
     In summary, our current study indicates that H.pylori infected population volunteers have 
reduced intragastric acidity compared to uninfected controls and that this is most marked 
close to the GEJ.  This observation may explain the negative association between the 
infection and GEJ disease and its complications.        
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FIGURE LEGENDS 
 
Fig 1. Schematic diagram of the relative positions of the 12 sensor pH catheter, 36 sensor 
manometer and SCJ (identified by attached metal clip) 
 
Fig 2. Median pH for 0-30 minute period after meal relative to LES and SCJ in H.pylori 
positive (HP+) and negative (HP-) subjects 
 
Fig 3. Relative reduction in parietal and chief cell densities at different gastric locations in 
H.pylori infected versus non-infected 
     Note: At the GE junction and distal stomach these cells are reduced by 80% whereas in 
the mid-body reduction was about 30%.  Biopsy locations:  JG: across SCJ above greater 
curve; JL1:  across SCJ above lesser curve;  JL2:  6mm distal SCJ;  JL3:  12mm distal SCJ;  
JL4:  18mm distal SCJ;  BG3:  Fundus;  BL:  mid-body lesser curve;  BG2:  mid-body 
greater curve;  BG1:  distal body greater curve;  IA:  incisura angularis;  Ant:  antrum.   
 
Supplement Fig 1. Flow diagram showing progress of study participants through each stage 
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ABSTRACT 
Objective:   Gastric acid secretory capacity in different anatomical regions, including the 
postprandial acid pocket, was assessed in H. pylori positive and negative volunteers in a 
Western population.  
 
Design:   We studied 31 H.pylori positive and 28 H.pylori negative volunteers, matched for 
age, gender and BMI.  Jumbo biopsies were taken at 11 pre-determined locations from the 
gastroesophageal junction and stomach.  Combined high resolution pHmetry (12 sensors) 
and manometry (36 sensors) was performed for 20 minutes fasted and 90 minutes 
postprandially. The squamocolumnar junction was marked with radio-opaque clips, and 
visualised radiologically.   Biopsies were scored for inflammation and density of parietal, 
chief and G cells immunohistochemically.  
 
Results:  Under fasting conditions, the H.pylori positives had less intragastric acidity 
compared to negatives at all sensors >1.1cm distal to the peak lower oesophageal sphincter 
(LES) pressure (p<0.01).  Postprandially, intragastric acidity was less in H.pylori positives at 
sensors 2.2, 3.3 and 4.4cm distal to the peak LES pressure (p<0.05), but there was no 
significant differences in more distal sensors. The postprandial acid pocket was thus 
attenuated in H.pylori positives.   
The H.pylori positives had a lower density of parietal and chief cells compared to H.pylori 
negatives in 10 of the 11 gastric locations (p<0.05).  17/31 of the H.pylori positives were 
CagA seropositive and showed a more marked reduction in intragastric acidity and 
increased mucosal inflammation.  
 
Conclusion: In population volunteers, H.pylori positives have reduced intragastric acidity 
which most markedly affects the postprandial acid pocket.    
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SUMMARY BOX 
 
WHAT IS ALREADY KNOWN? 
 
1. There is a negative association between H. pylori infection and both 
gastroesophageal reflux disease and oesophageal adenocarcinoma.   
2. The mechanism of this negative association is unclear but might be related to H. 
pylori reducing gastric acidity.  
3. The gastric acid which refluxes into the oesophagus originates from  the proximal 
gastric acid pocket.  
 
NOVEL FINDINGS: 
1. In population volunteers, intragastric acidity was less in those with H. pylori infection 
and this was most marked in the proximal stomach close to the gastroesophageal 
junction.   
2. The density of parietal cells and chief cells was reduced in H. pylori positives 
compared to negatives.   
3. The reduction in intragastric acidity and severity of inflammation were more marked 
in CagA positive versus CagA negative H. pylori infected subjects. 
 
CLINICAL IMPLICATIONS: 
 The reduced intragastric acidity close to the gastroesophageal junction in the H. 
pylori infected subjects provides a mechanism for the negative association between the 
infection and reflux disease and its complications.   
 
  
Page 32 of 63
https://mc.manuscriptcentral.com/gut
Gut
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
4 
 
INTRODUCTION 
   Helicobacter pylori (H.pylori) is a common bacterial infection of the stomach present in the 
majority of the world’s human population and resulting in varying degrees of inflammation of 
the underlying gastric mucosa.  The infection is acquired in early childhood and usually 
persists indefinitely unless specifically eradicated. [1] 
   One of the major medical advances of the past  25 years has been the discovery that this 
common infection plays an important role in the aetiology of duodenal and gastric ulcers and 
also of gastric cancer.[2]   Eradicating the infection produces a long-term cure for the majority 
of patients with peptic ulcers unrelated to NSAID therapy. There is also increasing evidence 
that eradication of the infection reduces the risk of gastric cancer.[3]  
   An unexplained observation regarding the infection is its negative association with 
gastroesophageal reflux disease (GERD) and its complications of Barrett’s oesophagus and 
oesophageal adenocarcinoma, with these disorders being less than half as common in 
infected subjects. [4, 5]   It has been postulated that this negative association may represent 
the gastric infection protecting against these oesophageal disorders.  If so, the falling 
incidence of the infection in the general population might explain the rising incidence of 
these oesophageal diseases.  
   One mechanism by which the infection might protect against oesophageal disease is by 
reducing the ability of the gastric mucosa to secrete acid and pepsin which are the 
constituents of gastric juice which can induce oesophageal damage.  The infection is known 
to exert varying effects on gastric secretory function.  In subjects with duodenal ulcers, the 
infection  produces a non-atrophic gastritis with well-maintained gastric secretory cell mass 
which secretes increased amounts of acid due to the infection inhibiting the gastrin-mediated 
negative feedback control of acid secretion.[6]  In patients who develop gastric cancer, the 
infection induces an atrophic gastritis with loss of gastric secretory cells and thus reduced 
acid secretion.  Only approximately 1 in 10 H.pylori infected subjects develop complicating 
ulcer disease or gastric cancer and relatively little is known about the effects of the chronic 
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infection on gastric secretory function in the 90% of infected subjects without these 
complications.[7]   If the degree of reduction in oesophageal disease in the H.pylori infected 
population is due to the infection reducing gastric acid secretion, then this suppression of 
acid secretion would need to be apparent in the majority of infected subjects. 
   Recent evidence indicates that it is the acidity of the gastric contents close to the 
gastroesophageal junction (GEJ), referred to as the acid pocket, which refluxes and causes 
oesophageal damage.[8]  It is also known that loss of gastric secretory cells due to H.pylori-
induced atrophic gastritis does not occur uniformly throughout the stomach but may be more 
marked at the periphery of the acid secreting mucosa.[9]   In assessing any potential 
protective effect of the infection against oesophageal damage, it is important to examine the 
structure and secretory function of different anatomical regions of the stomach as well as its 
overall secretory capacity. 
   The aim of our study was to assess gastric secretory status in different anatomical regions 
of the stomach and in subjects representative of the majority of the H.pylori infected 
population. 
   
METHODS & MATERIALS 
Subjects 
     Study participants were volunteers from the general population of the West of Scotland.   
Subjects who were currently taking, or had recently taken, proton pump inhibitors,  were 
currently using H2 receptor antagonists or had ever received H.pylori eradication therapy 
were excluded.  Recruitment was by general advertisement and from the NHS Scotland 
SHARE database.    
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Study design 
Study Day 1: Clinical measurements and Urea breath test 
     The presence and severity of any gastrointestinal symptoms was assessed  using the 
Short-Form Leeds Dyspepsia Questionnaire [10] and a medication history was recorded.  
Measurements of height, weight, waist and hip circumference were taken.  Volunteers were 
tested for H.pylori infection by C14 urea breath test.  Fasting serum and plasma samples 
were stored at -20˚C and later tested for H.pylori CagA IgG using ELISA (Genesis 
Diagnostics Ltd, Littleport, UK).  
 
Study day 2: Upper gastrointestinal endoscopy 
     Volunteers attended after an overnight fast for upper gastrointestinal endoscopy.   They 
were offered topical lidocaine throat spray or conscious sedation with midazolam 1-3mg.  
Biopsies were taken using large capacity biopsy forceps (Radial Jaw™ 4; Boston Scientific, 
Hemel Hempstead, UK) with a jaw span of 8mm.  Two junctional biopsies were taken 
perpendicular to the squamocolumnar junction (SCJ), one from lesser and one from greater 
curve,  and targeted to include squamous mucosa at the proximal end.  Three further 
junctional biopsies were taken longitudinally below the SCJ, aiming for end-to-end biopsies 
starting at 6, 12 and 18mm distal to the SCJ down the lesser curve.  In addition, six further 
gastric biopsies were taken from gastric fundus, mid-body on greater curve, mid-body on 
lesser curve, distal body on greater curve, incisura angularis and antrum.  Finally, two small 
metal radio-opaque clips were attached to the SCJ using a single use rotatable clip fixing 
device (QuickClip 2™; Olympus, Southend-on-Sea, UK). 
 
Biopsy specimen processing 
     Biopsies were immediately placed onto non-adherent dental wax and oriented flat.  More 
detailed information concerning the two-stage orientation method has been described 
elsewhere.[11]   The specimens were later embedded in agar on the filter paper without 
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further manipulation.  Staining was performed with conventional H&E, as well as monoclonal 
antibodies to H+/K+ATPase, pepsinogen I and gastrin. 
 
Study Day 3: Combined manometry and pH study 
     The volunteers attended after an overnight fast for combined high resolution manometry 
and pH studies.  The combined probe was  passed pernasally and positioned so that the 
most proximal pH sensor was 5cm above the lower oesophageal sphincter (LES), with the 
remaining eleven sensors lying across the sphincter and within the proximal stomach.  The 
relative positions of the 12 sensor pH catheter, 36 sensor manometer and SCJ is shown in 
Fig 1.  Manometry and pH data were recorded concurrently for a 20 minute fasting period.  
Subjects then consumed a standardised meal over ten minutes [400g Waitrose spaghetti 
bolognese ready meal and 100ml water (500kcal; 55.2g carbohydrate, 27.8g protein, 17.6g 
fat)].  Following this, manometry and pH recordings were continued for a further 90 minutes.  
An X-ray was taken before and after the meal to visualise the metal clips at the SCJ. 
 
Equipment 
High-resolution pHmetry    
     pH recordings were taken using a high resolution pH catheter (Synectics Medical Ltd, 
Enfield, UK).  This was a custom-made pH probe composed of 12 antimony pH electrodes 
with the most distal electrode situated 5mm from the tip of the catheter, with the other eleven 
electrodes 35, 46, 57, 68, 79, 90, 101, 112, 123, 134 and 169mm proximal to the tip.  The 
probe was calibrated prior to each study using pH buffer solution (Synmed Ltd, Enfield, UK) 
at pH 7.01 and pH 1.07.  Recordings were captured using Polygram Net software (Synectics 
Medical Ltd, Enfield, UK). 
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High-resolution manometry  
     Manometry was performed using a high resolution solid-state catheter with 7.5mm 
spacing between 36 circumferential sensors (Given Imaging, Hamburg, Germany).   
Calibration was performed prior to each study and In vivo calibration was carried out on a 
weekly basis and applied to each study to compensate for thermal drift.  Recordings were 
captured with ManoScan 360 high-resolution Manometry System and analysed with 
ManoView ESO v3.0.1 software (Given Imaging, Hamburg, Germany).   
 
Combined probe  
    The manometry and pH catheters were combined using two thin strips of Leukoplast 
Sleek waterproof tape (BSN Medical, Pinetown, SA) such that manometry sensor 25 was 
immediately adjacent to pH sensor 3.   
 
Data analysis 
Intragastric acid 
     The 90 minute postprandial period was split into three 30 minute periods for analysis.  
The median pH for each of the 12 pH sensors was calculated for the twenty minute fasting 
period and the three 30 minute postprandial periods.  Acid exposure at the GEJ was also 
examined by calculating the % of time pH <4.    
 
Manometry  
     Manometric characteristics were analysed in detail during fasting and the same three 
postprandial periods.  For each two minute period, one inspiratory point and one expiratory 
point was chosen from the longest period without interference from swallowing, coughing or 
transient lower oesophageal sphincter relaxations (TLESRs).  The mean pressure in 
inspiration and expiration was calculated for each of the 36 sensors over the twenty minute 
fasting period and thirty minute postprandial periods.  The peak LES pressure was taken as 
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the sensor showing the highest mean pressure.  The position of the SCJ was derived from 
the position of the metal clips relative to the combined manometry and pH sensors seen on 
X-ray. 
 
Histopathological Assessment 
A.   Studies using Conventional H&E: 
Glandular height:  The vertical height of epithelium starting from lamina propria to tip of 
gland were measured in 3 well-oriented and representative fields and expressed as “Total 
Thickness of Epithelium”.  To measure the “Glandular Height”, the same method was limited 
to areas of gland containing secretory cells, but not superficial foveolar epithelial cells.  All 
results were expressed as median (IQR) in mm. 
Inflammatory scoring:  The intensity of inflammatory infiltrate by polymorphonuclear (PMN) 
and mononuclear (MN) cells was scored semi-quantitively (0=none; 1=mild; 2=moderate; 
3=severe) as recommended in the Updated Sydney Classification of Gastritis [12].    A 
combined inflammatory score was calculated as the sum of these two scores.   Intestinal 
metaplasia (IM) was scored by estimating the proportion of epithelial surface covered by 
goblet cells. 
 
B.   Immunohistochemistry   
     The oriented biopsies, double embedded in agar and paraffin, were cut in standard 4-
micron thickness and immunostained individually for parietal cell, chief cell and G cells.  For 
parietal cells, we used a commercial mouse monoclonal anti-H+/K+ ATPase (Ab 2866, 
Abcam, Cambridge, UK) diluted at 1:20,000.  For Chief cells, a mouse monoclonal anti-
pepsinogen 1 antibody (Ab 50123, Abcam, Cambridge, UK) was used at dilution of 1:4000.  
The G cells were stained with anti-gastrin (Ab-16035, Abcam, Cambridge, UK) diluted at 
1:200.  A Thermo Quanto Detection Kit (TL-125-OHD, Thermo Fisher, UK) was used as 
secondary antibody. 
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Quantification of Secretory Cells: 
     To calculate the density of parietal cells, chief cells and G cells, absolute number of 
stained cells were counted at a magnification of 125X in 3 well-oriented and representative 
fields (1 mm2 each) and expressed as mean cell number per 1 mm2 area in each patient.  All 
selected areas must have had complete glands located in sagittal plane, in which the lamina 
propria was in bottom and luminal side of epithelium was in top. 
 
Statistical analysis 
     All continuous data are expressed as medians and interquartile ranges unless otherwise 
stated.  Comparison of variables between groups was made using the Mann-Whitney U test.  
Biopsy inflammatory scores are presented as crosstabulations and compared using Fisher’s 
exact test.  Significance for all statistical tests was set as p value <0.05. 
 
Ethics 
     The study protocol was approved by the West of Scotland Ethics Committee and all 
volunteers provided informed written consent. 
 
RESULTS 
     Of the 137 subjects assessed for eligibility for the study, 49 were excluded due to current 
or recent use of proton pump inhibitor (PPI) therapy (n=9) or history of previous H.pylori 
eradication therapy (n=8) or declining to participate following full explanation of the study 
protocol (n=32).  88 subjects proceeded to the urea breath test of which 31 were H.pylori 
positive and all of these went on to complete the full study protocol.  Of the 57 testing 
H.pylori negative, 28 went on to complete the study due to 1 withdrawing consent after the 
endoscopy and 28 not being selected to proceed in order to maintain matching of the 
positive and negative groups with respect to age, gender and body mass index (BMI) (Fig. 
S1).   
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     The 31 H.pylori positive and 28 H.pylori negative subjects who completed the study were 
well matched with respect to age (55 vs 56 years; p=0.95), gender (18/31 vs 18/28 males; 
p=0.84) and BMI (26.3 vs 26.8 kg/m2; p=0.72). There were 7 current smokers in the H.pylori 
positive group compared to 1 current smoker in the H.pylori negative group (p=0.035). 
     The median dyspepsia score for H.pylori positives was 2.0 (range 0-9) compared to 0 
(range 0-3) for the H.pylori negative subjects (p=0.002).  17/31 (54.8%) of the H.pylori 
positives were taking no medication compared to 10/29 (35.7%) of the H.pylori negative 
subjects.  The most frequent medications were antihypertensives, statins, antidepressants 
and inhalers for asthma.  No subject was taking medications known to affect gastric 
secretion.  
     At endoscopy, 4 H.pylori positive subjects had a hiatus hernia (2-4cm in length), 1 subject 
had LA Grade A reflux esophagitis, and one subject had 3cm of Barrett’s mucosa.  None of 
the H.pylori negatives had a hiatus hernia, although two subjects had reflux esophagitis (LA 
grade A and B).  
 
Gastroesophageal Acidity 
     Under fasting conditions, the H.pylori positive subjects had less intragastric acidity 
compared to the H.pylori negatives at all sensors more than 1.1cm distal to the peak LES 
pressure (Table 1).  The fall from neutral oesophageal pH to highly acidic intragastric pH 
also occurred more abruptly in the H.pylori negatives.  At the sensor 3.3cm distal to the peak 
LES pressure, the median pH in the H.pylori negatives had fallen to 2.27 compared to 6.13 
in the positives (p<0.001).  The radio-opaque clips indicated that this pH sensor was 1.8cm 
distal to the SCJ.  
     Throughout the three postprandial periods, intragastric acidity was significantly less in the 
H.pylori positives at the pH sensors placed 2.2, 3.3 and 4.4cm distal to the peak pressure of 
the LES but no significant difference was detected by the more distal sensors placed at 5.5 
and 6.6cm distal to this reference point (Table 1).  These three sensors detecting a 
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significant difference in gastric acidity between the two groups were those closest to the GEJ 
with the most proximal of them being only 0.6cm distal to the SCJ (Fig. 2).   
     The % of time pH<4 for each of the three postprandial periods was significantly greater in 
the H.pylori negatives versus positive subjects for the electrodes extending 3cm distal to the 
peak LES pressure, at the peak LES pressure and also extending 1.1cm above the peak 
LES pressure (Table 2). 
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Table 1. Median (IQR) pH values at sensors relative to peak LES pressure comparing H.pylori negative (n=28) and positive (n=31) groups 
during 20 minute fasting period and three 30 minute postprandial periods.. 
 
 Fasting  0-30 minutes  30-60 minutes  60-90 minutes 
Sensor location HP- HP+ p value  HP- HP+ p value  HP- HP+ p value  HP- HP+ p value 
5cm proximal 
7.20 
(0.70) 
7.19 
(0.74) 
0.933  
7.28 
(0.79) 
7.03 
(0.72) 
0.274  
7.18 
(0.81) 
6.98 
(0.77) 
0.499  
7.13 
(0.85) 
7.04 
(0.67) 
0.861 
1.1cm proximal 
7.33 
(0.78) 
7.37 
(0.62) 
0.525  
7.20 
(0.96) 
7.29 
(0.68) 
0.443  
7.06 
(1.42) 
7.00 
(0.75) 
0.705  
7.13 
(1.77) 
6.96 
(1.27) 
0.786 
Peak LES pressure 
7.34 
(0.79) 
7.28 
(0.51) 
0.499  
6.83 
(0.62) 
6.94 
(0.66) 
0.339  
6.76 
(1.02) 
6.88 
(0.48) 
0.391  
6.56 
(1.27) 
6.77 
(0.58) 
0.245 
1.1cm distal 
7.06 
(1.63) 
7.13 
(0.51) 
0.213  
5.90 
(1.88) 
6.74 
(1.18) 
0.063  
5.25 
(4.19) 
6.40 
(1.72) 
0.053  
6.43 
(4.80) 
6.38 
(2.21) 
0.306 
2.2cm distal 
5.79 
(4.26) 
6.94 
(1.38) 
0.004  
3.17 
(3.07) 
5.55 
(2.84) 
0.005  
1.95 
(1.00) 
3.21 
(4.46) 
0.005  
2.20 
(2.82) 
3.82 
(4.40) 
0.024 
3.3cm distal 
2.27 
(2.58) 
6.13 
(5.06) 
<0.001  
2.46 
(2.75) 
4.26 
(2.84) 
0.006  
1.59 
(1.08) 
2.07 
(2.29) 
0.009  
1.61 
(0.82) 
2.30 
(3.08) 
0.010 
4.4cm distal 
1.70 
(1.16) 
4.11 
(4.95) 
<0.001  
4.09 
(3.17) 
4.87 
(1.60) 
0.025  
1.81 
(2.09) 
2.93 
(3.25) 
0.032  
1.67 
(0.94) 
2.01 
(2.10) 
0.031 
5.5cm distal 
1.68  
(0.66) 
2.88 
(3.66) 
<0.001  
4.62 
(1.21) 
4.79 
(1.36) 
0.309  
2.13 
(2.02) 
3.48 
(2.89) 
0.062  
1.74 
(1.45) 
2.36 
(2.74) 
0.078 
6.6cm distal 
1.62 
(3.66) 
2.39 
(3.06) 
0.003  
4.60 
(1.17) 
4.68 
(0.96) 
0.313  
3.39 
(2.19) 
4.10 
(2.23) 
0.158  
2.08 
(1.58) 
3.87 
(2.35) 
0.184 
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Table 2: Median (IQR) percentage time pH<4 at sensors relative to peak LES pressure comparing H.pylori negative (n=28) and positive 
(n=31) groups during 20 minute fasting period and three 30 minute postprandial periods. 
 
 Fasting  0-30 minutes  30-60 minutes  60-90 minutes 
Sensor location HP- HP+ p value  HP- HP+ p value  HP- HP+ p value  HP- HP+ p value 
5cm proximal 
0.0 
(0.0) 
0.0 
(0.0) 
0.271  
0.2 
(0.4) 
0.0 
(0.7) 
0.384  
0.0 
(0.7) 
0.0 
(0.5) 
0.354  
0.0 
(1.2) 
0.0 
(0.5) 
0.280 
1.1cm proximal 
1.1 
(2.8) 
0.0 
(0.1) 
0.004  
3.0 
(2.8) 
0.0 
(1.3) 
0.005  
2.1 
(14.3) 
0.3 
(2.8) 
0.046  
2.0 
(6.4) 
0.6 
(0.7) 
0.088 
Peak LES pressure 
1.7 
(4.9) 
0.0 
(1.0) 
0.001  
4.2 
(6.5) 
0.6 
(2.0) 
<0.001  
3.7 
(15.3) 
0.9 
(4.4) 
0.017  
2.7 
(8.7) 
1.2 
(7.4) 
0.162 
1.1cm distal 
6.6 
(30.6) 
1.0 
(7.3) 
0.008  
15.4 
(30.8) 
1.8 
(19.3) 
0.003  
33.9 
(67.0) 
5.2 
(33.0) 
0.021  
7.6 
(77.1) 
10.1 
(25.5) 
0.264 
2.2cm distal 
32.1 
(65.4) 
2.8 
(21.7) 
0.004  
62.9 
(49.7) 
22.6 
(51.8) 
0.001  
90.8 
(28.7) 
63.2 
(81.1) 
0.002  
81.1 
(51.7) 
55.1 
(84.7) 
0.026 
3.3cm distal 
75.6 
(48.2) 
13.5 
(75.6) 
0.003  
64.9 
(45.7) 
46.4 
(66.1) 
0.004  
99.7 
(9.3) 
91.5 
(49.0) 
0.017  
99.2 
(3.2) 
91.0 
(59.1) 
0.009 
4.4cm distal 
93.0 
(42.3) 
42.4 
(42.3) 
<0.001  
44.2 
(69.2) 
15.1 
(53.0) 
0.032  
99.0 
(18.7) 
88.9 
(77.9) 
0.111  
100.0 
(3.0) 
99.4 
(20.7) 
0.043 
5.5cm distal 
97.6 
(14.0) 
60.4 
(62.1) 
0.001  
24.3 
(47.4) 
12.9 
(48.5) 
0.375  
96.2 
(37.3) 
86.1 
(88.2) 
0.083  
100.0 
(1.2) 
99.8 
(80.1) 
0.105 
6.6cm distal 
99.5 
(4.8) 
84.8 
(61.6) 
0.011  
13.7 
(46.4) 
9.9 
(21.7) 
0.355  
82.8 
(72.6) 
38.5 
(99.3) 
0.104  
99.8 
(9.0) 
96.8 
(61.0) 
0.099 
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Gastric Histopathology 
A.   Conventional H&E Staining 
Inflammation 
     The H.pylori positives had a greater combined inflammatory cell infiltrate at each of the 
11 biopsy sites compared to the H.pylori negatives (Table 3).  The increased combined 
inflammatory cell infiltrate in the H.pylori positives consisted of a mixture of PMN cells and 
MN cells and tended to be more intense close to the SCJ, lesser curve, distal stomach, 
incisura and antrum compared to the gastric fundus and mid-body (p<0.05 for each).  The 
H.pylori negatives had a MN cell infiltrate limited to the SCJ and also to a lesser extent at the 
antrum and angularis incisura but its intensity was less than that of the H.pylori positives at 
these sites.  There was minimal evidence of PMN cell infiltrate at any location in the H.pylori 
negatives.  
 
Intestinal Metaplasia 
     Intestinal metaplasia was identified in 14 of the 31 H. pylori positive subjects.  In 7 of 
these it was limited to one or more of the biopsies from mid-body lesser curve, distal body 
greater curve, incisura angularis and antrum.  In 3 of the subjects it was present in at least 
one of the above sites and also in the biopsies close to the SCJ.  In a further 3 it was limited 
to the region close to the SCJ.  In 1 subjects it was present in each biopsy except for one of 
the biopsies from the SCJ.  
     Intestinal metaplasia was identified in only four of the 28 H.pylori negative subjects.  In 
three of these it was only seen in the biopsies across the SCJ and in the fourth subject it was 
only seen in the biopsy from the fundus. 
 
Gastric Gland Height 
     The height of the gastric secretory glands was significantly reduced in the H.pylori 
positive versus negative subjects throughout the gastric mucosa except for the biopsies 
taken across the SCJ (Table 4).  
Page 44 of 63
https://mc.manuscriptcentral.com/gut
Gut
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
16 
 
 
Table 3: Cross-tabulation table showing the number of subjects within the H.pylori negative (HP-) and positive (HP+) groups with each combined 
inflammatory score (0-6) at the 11 different gastric biopsy locations. 
 
Combined 
Inflammatory 
score 
Across SCJ 
(greater curve) 
 Across SCJ 
(lesser curve) 
  
6mm distal SCJ 
  
12mm distal SCJ 
  
18mm distal SCJ 
  
HP- HP+   HP-  HP+   HP- HP+   HP- HP+   HP-  HP+    
0 8 0  1 0  15 0  25 0  26 0    
1 10 0  16 0  8 1  2 1  1 4    
2 9 0  6 0  1 3  0 6  0 7    
3 1 7  0 7  0 10  0 8  1 9    
4 0 11  0 11  0 11  0 11  0 5    
5 0 11  0 9  0 5  0 4  0 4    
6 0 1  0 0  0 0  0 0  0 1    
Fisher’s Exact 
test 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001   
            
Combined 
Inflammatory 
score 
 
Fundus 
 Mid-body, 
 lesser curve 
 Mid-body, 
 greater curve 
 Distal body, 
greater curve 
  
Incisura angularis 
  
Antrum 
HP- HP+   HP- HP+   HP- HP+   HP- HP+   HP- HP+   HP- HP+  
0 25 0  25 0  27 0  24 0  17 0  14 0 
1 1 5  2 0  0 2  2 0  9 0  9 0 
2 0 6  0 6  0 8  0 7  1 0  0 0 
3 1 12  0 11  0 8  0 5  0 6  1 1 
4 0 5  0 6  1 5  1 7  0 3  0 6 
5 0 1  0 4  0 4  1 8  0 13  0 11 
6 0 2  0 4  0 4  0 4  0 9  0 8 
Fisher’s Exact 
test 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001 
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Table 4. Median (IQR) of glandular thickness and densities of parietal and chief cells at each biopsy location comparing H.pylori negatives (n=28) and 
positives (n=31). 
 
 Glandular Thickness (mm)  Parietal cell density (cells/mm
2
)  Chief cell density (cells/mm
2
) 
Biopsy location H.pylori - H.pylori + P value  H.pylori - H.pylori + P value  H.pylori - H.pylori + P value 
Across SCJ, Greater curve 
0.30 
(0.20–0.30) 
0.25 
(0.20–0.30) 
0.515  
67 
(0-162) 
17 
(10-39) 
0.185  
94 
(0-156) 
22 
(3-52) 
0.150 
Across SCJ, Lesser curve 
0.28 
(0.0–0.30) 
0.20 
(0.10–0.30) 
0.461  
50 
(14-127) 
9 
(0-51) 
0.012  
89 
(17-139) 
22 
(0-62) 
0.017 
6mm distal SCJ 
0.35 
(0.30–0.40) 
0.30 
(0.20–0.30) 
0.006  
231 
(175-286) 
144 
(59-190) 
<0.001  
245 
(203-272) 
129 
(52-190) 
<0.001 
12mm distal SCJ 
0.40 
(0.40–0.45) 
0.30 
(0.30–0.35) 
<0.001  
317 
(300-362) 
193 
(137-250) 
<0.001  
379 
(312-404) 
206 
(125-299) 
<0.001 
18mm distal SCJ 
0.45 
(0.40–0.50) 
0.35 
(0.30–0.40) 
<0.001  
357 
(334-383) 
241 
(201-283) 
<0.001  
404 
(374-421) 
273 
(194-353) 
<0.001 
Fundus 
0.43 
(0.40–0.45) 
0.40 
(0.35–0.40) 
0.008  
347 
(285-401) 
258 
(220-292) 
<0.001  
421 
(384-451) 
310 
(255-389) 
<0.001 
Mid-body, Lesser curve 
0.40 
(0.40–0.45) 
0.35 
(0.30–0.40) 
<0.001  
361 
(316-381) 
235 
(166-290) 
<0.001  
401 
(367-419) 
285 
(206-367) 
<0.001 
Mid-body, Greater curve 
0.45 
(0.40–0.45) 
0.35 
(0.30–0.40) 
<0.001  
356 
(318-398) 
250 
(201-297) 
<0.001  
420 
(372-441) 
305 
(243-354) 
<0.001 
Distal body, Greater curve 
0.40 
(0.35–0.49) 
0.30 
(0.25–0.35) 
<0.001  
322 
(293-349) 
107 
(25-263) 
<0.001  
365 
(296-398) 
136 
(17-292) 
<0.001 
Incisura Angularis 
0.33 
(0.30–0.40) 
0.25 
(0.20–0.30) 
<0.001  
203 
(124-250) 
12 
(0-87) 
<0.001  
215 
(98-296) 
7 
(0-99) 
<0.001 
Antrum 
0.20 
(0.13–0.30) 
0.20 
(0.0–0.20) 
0.041  
40 
(6-67) 
7 
(0-18) 
0.002  
22 
(1-85) 
0 
(0-5) 
<0.001 
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B.   Immunohistochemistry 
Parietal and Chief Cell Density: 
     The H.pylori positives had a significant reduction in density of both parietal and chief cells 
compared to H.pylori negatives, and this was seen at each of the 11 intragastric locations 
assessed except for the SCJ greater curve where the difference did not achieve statistical 
significance (Table 4).  The degree of reduction was similar for the two cell types.     
     The depletion of both cells in the H.pylori positives versus negatives was more marked in 
the biopsies taken from the distal gastric mucosa (i.e. antrum, incisura angularis, and distal 
body greater curve) being reduced by 67-100% compared to that observed in the more 
central region of the oxyntic mucosa (fundus and mid-body) at 26-35% (Fig. 3).   In addition, 
the length of mucosa extending distal to the SCJ which contained no detectable parietal cells 
was greater in the H.pylori positives versus negatives (1.5mm vs 1.0mm; p=0.013). 
However, the degree of reduction in specialised cell density in the biopsies taken 6mm and 
12mm distal to the SCJ (38-47%) was not dissimilar from that observed in the more central 
oxyntic mucosa (i.e. fundus and mid-body) (26-35%) (Fig. 3).   
 
G Cell Density 
     The density of G cells was reduced in the antrum of the H.pylori positive versus negative 
subjects [48 (IQR: 31-86) vs. 91 (64-129), p<0.001], but the converse was seen with respect 
to the biopsies taken from the distal body region [0 (IQR: 0-32) vs 0 (0-0), p=0.007]. 
 
Intragastric Acidity and Histology in CagA Positive H.pylori Subjects 
     Seventeen of the H.pylori positives were CagA seropositive and fourteen CagA 
seronegative.  The associations with reduced intragastric acidity in comparison with H.pylori 
negatives was more apparent for the CagA positives being significant for five of the six 
intragastric sites both fasting and after the meal in the CagA positives but in only two of the 
six intragastric sites for the CagA negatives and only under fasting conditions (Table 1 – 
supplement).  There was a statistically significant difference between the CagA negative and 
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CagA positives for only two of the six sites during fasting and one of the six sites after the 
meal.   
     The CagA positives had a significantly greater combined inflammatory cell infiltrate 
evident at three of the eleven biopsy locations (6mm and 18mm distal SCJ, and distal body 
greater curve), compared to the CagA negatives (Table 2 – supplement).  The reduction in 
parietal and chief cell density was significant at each intragastric location for both CagA 
positive and negative subjects with no apparent difference between these two groups.   
 
DISCUSSION 
     In our volunteers recruited from the general population of the West of Scotland, those 
with H.pylori infection had less intragastric acidity both under fasting conditions and following 
a meal compared to uninfected volunteers matched for age, gender and BMI.  In addition, 
those with the infection had a reduced density of both acid secreting parietal cells and 
pepsin producing chief cells compared to those uninfected.  These findings indicate that 
H.pylori infection within our Western population is associated with a less acidic and 
proteolytic intragastric environment. 
     The reduced intragastric acidity in the H.pylori positive subjects was apparent throughout 
the stomach under fasting conditions.  After the meal, however, the reduced acidity in the 
H.pylori positives was evident within the first few centimetres distal to the GEJ but no 
significant difference in acidity was apparent in the main body of the stomach.  There was 
also evidence of increased acidity after the meal in the H.pylori negatives right at the SCJ 
junction and extending 2cm above it indicating increased intrasphincteric acid reflux.  We 
and others have previously reported that the proximal region of the stomach close to the 
GEJ largely escapes the buffering effect of ingested food and may remain highly acidic after 
a meal.[13,14,15]  This phenomenon has been called the acid pocket and is thought to be 
important in GERD induced oesophageal damage after a meal when reflux is most common.  
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It is therefore interesting that it is at this region close to the GEJ where the reduced acidity 
was most apparent in the H.pylori infected subjects. 
     What is the reason for the reduced acidity in the H.pylori positives after a meal, being 
most marked close to the GEJ?  There was no evidence that the depletion in parietal cell 
density in the H.pylori positives was more pronounced over the few centimetres close to the 
GEJ compared to other regions in the stomach.  Inflammation may also inhibit gastric 
secretory function [16] and this was slightly increased close to the GEJ and also in the distal 
stomach compared to the mid-body gastric mucosa.   The elevation of intragastric pH 
following the meal in the H.pylori positives being most marked close to the GEJ may simply 
reflect the relative intragastric distribution of gastric juice and ingested food.  Following a 
meal, the food occupies the centre of the stomach and the secreted gastric juice,  the region 
close to the stomach wall which secretes it.  Impaired acid secretion will elevate the pH of 
the gastric juice and this will be most apparent close to the stomach wall.  In contrast, the 
central region of the stomach will reflect the pH of the food and thus will be relatively 
unaffected by changes in the acidity of secreted juice.  The effect of H.pylori on intragastric 
pH after the meal being most evident close to the GEJ may be due to this region being close 
to the wall of the stomach.  
     Whatever the explanation for the changes in acidity between H.pylori positives and 
negatives being most marked close to the GEJ, after the meal, the observation is likely to be 
important with respect to the propensity of gastroesophageal reflux producing oesophageal 
damage.  It is well recognised that gastric juice which refluxes into the oesophagus is that 
present close to the GEJ and also that reflux most commonly occurs during the postprandial 
period when TLESRs are most frequent. [17] 
     The reduction in parietal cell density observed in the H.pylori positive subjects was 
associated with a similar reduction in chief cell density.  This is consistent with the infection 
and inflammation causing a loss in gastric glands and also with the previous literature 
showing that the development of parietal and chief cells is intimately linked.[18]   We did not 
measure the secretion of pepsin and other digestive enzymes produced by the chief cells but 
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their reduced density is likely to be associated with reduced secretory capacity after the 
meal.  Reduction in gastric juice peptic activity has previously been reported in H.pylori 
infected subjects.[19]   The peptic activity of the gastric juice is as important, and arguably 
more important than its acidity, with respect to the ability to damage oesophageal mucosa 
and therefore the reduction in both specialised cells is likely to represent a substantial 
reduction in the damaging capacity of reflux gastric juice in H.pylori infected subjects. [20]  
     There was a reduction in the density of G cells in the antrum of the H.pylori positives 
indicating a depletion of antral as well as oxyntic glands.  In contrast, G cell density in the 
distal body mucosa of the H. pylori positives was higher than in the H. pylori negative 
subjects.  This can be explained by the distal acid secreting body mucosa, which does not 
have G cells, being replaced by an antral-like mucosa that contains G cells (a process that 
has been called “antralization”).  This process can be associated with the development of 
pseudo-pyloric metaplasia, also called spasmolytic polypeptide expressing metaplasia 
(SPEM). [21-24]  This is consistent with our observation that the reduction in parietal and 
chief cell densities in H. pylori positives was most pronounced in the distal body mucosa.  
Together these findings are likely to represent the previously reported proximal progression 
of the junction between the antrum and body type mucosa leading to shrinkage in the 
surface area of the stomach covered by oxyntic mucosa in H. pylori atrophic gastritis.  [25]     
     There are few previous studies assessing gastric secretory function in H.pylori infected 
healthy volunteers in the Western world.  In a retrospective analysis of 95 healthy, young 
male volunteers (age 19-26 years) Smith et al reported that the 8 seropositive for H.pylori 
had similar intragastric acidity to the other 87. [26]   In a retrospective analysis of 136 healthy 
volunteers, Peterson et al reported reduced basal acid output but no significant difference in 
gastrin stimulated peak acid output or meal stimulated acid output assessed by intragastric 
titration in H.pylori seropositives.[27]  In a prospective study of 206 healthy volunteers, 
Feldman et al. in 1996 reported reduced gastrin stimulated peak acid output and reduced 
basal pepsin output in those with H.pylori detected histologically in gastric biopsies.[28]   In 
1998, our own group reported a reduced acid secretory response to gastrin stimulation in 20 
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H.pylori positive versus 24 H.pylori negative healthy volunteers.[29]   Several studies in the 
Japanese population have reported reduced gastric secretory function in H.pylori positive 
healthy volunteers.[30,31]  
     Our current study differs from previously published studies in a number of important 
respects.  Firstly, we aimed to study subjects representative of the general population 
infected with H.pylori  rather than asymptomatic healthy volunteers.  Secondly, by using  
intragastric pH sensors, we avoided the use of non-physiological gastric stimuli, gastric 
aspiration or intragastric titration which may not be representative of the subjects usual 
gastric functioning.   Thirdly, we focused on the middle-aged population rather than young 
students as the former is the population in whom reflux disease manifests itself.  Finally, and 
probably most critically, we employed a technique which allowed us to assess the acidity in 
different regions of the stomach and in particular close to the GEJ.  
     Our observation that gastric acidity was reduced most markedly close to the GEJ is 
interesting in the light of the previously reported but unexplained observations by Feldman et 
al in 1999.  They observed that in healthy volunteers, eradication of H.pylori did not alter 
basal or meal-stimulated gastric acid secretion assessed by intragastric titration but did 
result in a 2-3 fold increase in gastroesophageal acid reflux.[32]   In the light of our current 
study, the observed increase in gastroesophageal acid reflux may have been explained by 
the H.pylori infection reducing intragastric acidity close to the GEJ.  
     Is our finding of reduced gastric secretory function in the H.pylori infected population a 
peculiar feature of our West of Scotland population or relevant to the wider Western 
community?  H.pylori induced atrophic gastritis and reduced acid secretory function is 
associated with gastric cancer and the prevalence of the two correlates at a population 
level.[33]  The incidence of gastric cancer in Scotland is 9.7 /100,00py and similar to that of 
Western European and North American countries and substantially lower than that of 
Eastern European and Far Eastern countries.[34]  This would suggest that our findings of 
reduced acid secretory function is representative of what is happening in Western countries.   
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     Though our study demonstrates that the H.pylori infected general adult population has 
less intragastric acidity than the uninfected population, this association does not necessarily 
indicate that the reduced intragastric acidity is caused by the infection.  However, causal 
association seems highly likely as H.pylori gastritis is recognised to cause loss of gastric 
glands and impaired secretory function.  In addition, the more marked changes in gastric 
secretory function in those with the more virulent CagA strain supports it being caused by 
the infection.  Confirming causality by an intervention study has potential problems as 
H.pylori-induced loss of gastric glands is generally regarded as being irreversible. 
     In summary, our current study indicates that H.pylori infected population volunteers have 
reduced intragastric acidity compared to uninfected controls and that this is most marked 
close to the GEJ.  This observation may explain the negative association between the 
infection and GEJ disease and its complications.        
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FIGURE LEGENDS 
 
Fig 1. Schematic diagram of the relative positions of the 12 sensor pH catheter, 36 sensor 
manometer and SCJ (identified by attached metal clip) 
 
Fig 2. Median pH for 0-30 minute period after meal relative to LES and SCJ in H.pylori 
positive (HP+) and negative (HP-) subjects 
 
Fig 3. Relative reduction in parietal and chief cell densities at different gastric locations in 
H.pylori infected versus non-infected 
     Note: At the GE junction and distal stomach these cells are reduced by 80% whereas in 
the mid-body reduction was about 30%.  Biopsy locations:  JG: across SCJ above greater 
curve; JL1:  across SCJ above lesser curve;  JL2:  6mm distal SCJ;  JL3:  12mm distal SCJ;  
JL4:  18mm distal SCJ;  BG3:  Fundus;  BL:  mid-body lesser curve;  BG2:  mid-body 
greater curve;  BG1:  distal body greater curve;  IA:  incisura angularis;  Ant:  antrum.   
 
Supplement Fig 1. Flow diagram showing progress of study participants through each stage 
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Fig 1. Schematic diagram of the relative positions of the 12 sensor pH catheter, 36 sensor manometer and 
SCJ (identified by attached metal clip)  
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Fig 2. Median pH for 0-30 minute period after meal relative to LES and SCJ in H.pylori positive (HP+) and 
negative (HP-) subjects  
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Fig 3. Relative reduction in parietal and chief cell densities at different gastric locations in H.pylori infected 
versus non-infected.        Note: At the GE junction and distal stomach these cells are reduced by 80% 
whereas in the mid-body reduction was about 30%.  Biopsy locations:  JG: across SCJ above greater curve; 
JL1:  across SCJ above lesser curve;  JL2:  6mm distal SCJ;  JL3:  12mm distal SCJ;  JL4:  18mm distal 
SCJ;  BG3:  Fundus;  BL:  mid-body lesser curve;  BG2:  mid-body greater curve;  BG1:  distal body greater 
curve;  IA:  incisura angularis;  Ant:  antrum.    
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Table S1: Median (IQR) pH in H.pylori negatives (n=28), H.pylori positive CagA negatives (n=14) and H.pylori positive CagA 
positives (n=17) during 20 minute fasting and three 30 minute postprandial periods.   Note: *Indicates statistically different 
from H.pylori negatives. ‡Indicates statistically different from H.pylori positive CagA negatives  (p<0.05). 
 Fasting  0-30 minutes  30-60 minutes  60-90 minutes 
Sensor location HP- HP+ 
CagA- 
HP+ 
CagA+ 
 HP- HP+ 
CagA- 
HP+ 
CagA+ 
 HP- HP+ 
CagA- 
HP+ 
CagA+ 
 HP- HP+ 
CagA- 
HP+ 
CagA+ 
5cm proximal 7.20 
(0.70) 
7.22 
(0.68) 
7.06 
(0.64) 
 7.28 
(0.79) 
7.11 
(0.80) 
6.97 
(0.64) 
 7.18 
(0.81) 
7.01 
(0.83) 
6.93 
(0.61) 
 7.13 
(0.85) 
7.09 
(0.90) 
7.00 
(0.85) 
1.1cm proximal 7.33 
(0.78) 
7.65 
(0.75) 
7.32 
(0.53) 
 7.20 
(0.96) 
7.55 
(0.67) 
7.20 
(0.59) 
 7.06 
(1.42) 
6.97 
(1.46) 
7.00 
(0.60) 
 7.13 
(1.77) 
6.96 
(0.79) 
6.95 
(0.83) 
Peak LES pressure 7.34 
(0.79) 
7.52 
(0.51) 
7.18 
(0.31) 
 6.83 
(0.62) 
7.02 
(0.77) 
6.89 
(0.63) 
 6.76 
(1.02) 
6.93 
(1.02) 
6.80 
(0.39) 
 6.56 
(1.27) 
6.79 
(0.70) 
6.77 
(0.56) 
1.1cm distal 7.06 
(1.63) 
7.13 
(1.65) 
7.13 
(0.40) 
 5.90 
(1.88) 
6.66 
(4.46) 
6.74* 
(1.10) 
 5.25 
(4.19) 
6.36 
(2.52) 
6.55 
(1.79) 
 6.43 
(4.80) 
5.96 
(2.60) 
6.48 
(1.21) 
2.2cm distal 5.79 
(4.26) 
6.19 
(4.53) 
7.13*‡ 
(0.70) 
 3.17 
(3.07) 
4.38 
(3.76) 
6.25* 
(1.84) 
 1.95 
(1.00) 
2.19 
(3.02) 
5.72* 
(4.69) 
 2.20 
(2.82) 
3.37 
(4.28) 
5.86* 
(4.65) 
3.3cm distal 2.27 
(2.58) 
3.16 
(4.94) 
6.76* 
(3.22) 
 2.46 
(2.75) 
3.58 
(2.67) 
5.16* 
(1.92) 
 1.59 
(1.08) 
1.86 
(1.85) 
2.61*‡ 
(3.73) 
 1.61 
(0.82) 
2.08 
(1.32) 
2.86* 
(4.06) 
4.4cm distal 1.70 
(1.16) 
3.60* 
(4.99) 
4.11* 
(4.09) 
 4.09 
(3.17) 
4.48 
(1.51) 
5.28* 
(1.78) 
 1.81 
(2.01) 
2.54 
(1.70) 
3.85* 
(3.67) 
 1.67 
(0.94) 
1.89 
(1.75) 
2.19* 
(3.39) 
5.5cm distal 1.68 
(0.66) 
2.18* 
(2.26) 
4.17* 
(4.17) 
 4.62 
(1.21) 
4.70 
(1.31) 
4.97 
(1.61) 
 2.13 
(2.02) 
2.99 
(2.64) 
4.36* 
(3.16) 
 1.74 
(1.45) 
1.84 
(1.94) 
2.56* 
(2.78) 
6.6cm distal 1.62 
(3.66) 
1.80 
(1.46) 
4.11*‡ 
(4.72) 
 4.60 
(1.17) 
4.66 
(0.77) 
4.68 
(1.13) 
 3.39 
(2.19) 
3.76 
(2.10) 
4.35 
(2.23) 
 2.08 
(1.58) 
2.15 
(2.09) 
3.18 
(3.56) 
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Table S2: ross-tabulation table comparing the number of H.pylori positive CagA negative (HP+ CagA-) and H.pylori positive CagA positive 
(HP+ CagA+) subjects with each combined inflammatory score (0-6) at all gastric biopsy locations. 
 
 
Combined 
Inflammatory 
score 
Across SCJ 
(above greater 
curve) 
 Across SCJ 
(above lesser 
curve) 
  
6mm distal SCJ 
  
12mm distal SCJ 
  
18mm distal SCJ 
  
HP+ 
CagA- 
HP+ 
CagA+ 
 HP+ 
CagA- 
HP+ 
CagA+ 
 HP+ 
CagA- 
HP+ 
CagA+ 
 HP+ 
CagA- 
HP+ 
CagA+ 
 HP+ 
CagA- 
HP+ 
CagA+ 
   
0 0 0  0 0  0 0  0 0  0 0    
1 0 0  0 0  1 0  0 1  2 2    
2 0 0  0 0  3 0  5 1  5 2    
3 3 4  2 5  1 9  4 4  5 4    
4 5 6  5 6  6 5  4 7  0 5    
5 5 6  4 5  2 3  0 4  0 4    
6 0 1  0 0  0 0  0 0  1 0    
Fisher’s Exact 
test 
p=1.000  p=0.449  p=0.009  p=0.084  p=0.034   
 
 
Combined 
Inflammatory 
score 
           
 
Fundus 
 Mid-body lesser 
curve 
 Mid-body greater 
curve 
 Distal body 
greater curve 
 Incisura 
angularis 
  
Antrum 
HP+ 
CagA- 
HP+ 
CagA+ 
 HP+ 
CagA- 
HP+ 
CagA+ 
 HP+ 
CagA- 
HP+ 
CagA+ 
 HP+ 
CagA- 
HP+ 
CagA+ 
 HP+ 
CagA- 
HP+ 
CagA+ 
 HP+ 
CagA- 
HP+ 
CagA+ 
0 0 0  0 0  0 0  0 0  0 0  0 0 
1 2 3  0 0  1 1  0 0  0 0  0 0 
2 3 3  4 2  5 3  7 0  0 0  0 0 
3 7 5  6 5  1 7  1 4  2 4  1 0 
4 1 4  2 4  4 1  3 4  3 0  4 2 
5 0 1  1 3  2 2  2 6  7 6  6 5 
6 1 1  1 3  1 3  1 3  2 7  2 6 
Fisher’s Exact 
test 
p=0.803  p=0.579  p=0.158  p=0.012  p=0.120  p=0.343 
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